← FDA DRUG APPROVALS

FDA ANDA · ANDA089959

PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN

Sponsor: SANDOZ

APPLICATION
ANDA089959
TYPE
ANDA
ORIGINAL APPROVAL
1989-07-18
LATEST ACTION
2001-01-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 650MG, PROPOXYPHENE HYDROCHLORIDE 65MG · TABLET · ORAL

Approval history

2001-01-08Manufacturing (CMC) · Supplement 8AP
1998-05-11Manufacturing (CMC) · Supplement 6AP
1996-09-25Manufacturing (CMC) · Supplement 7AP
1993-06-28Labeling · Supplement 5AP
1992-04-07Manufacturing (CMC) · Supplement 3AP
1991-05-17Labeling · Supplement 4AP
1990-08-22Manufacturing (CMC) · Supplement 2AP
1989-10-26Labeling · Supplement 1AP
1989-07-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →